Accepted at 3:46 p.m. Oct, 31, 2023 by Alex
Author: Alfonsoglez27
Related Note: 1481335874189
Rationale for change

Diversity is the main characteristic

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid

Sketchy

Watch Plasma Cell Neoplasms
Sketchy 2

Watch Plasma Cell Dyscrasias SOAP
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize


Review Multiple Myeloma
Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Plasma Cell Dyscrasias and Myeloproliferative Disease: Multiple Myeloma
OME

Additional Resources
Atlas:

Other:
One by one
Empty field
Changed Tags
#AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::Plasma_Cell_Dyscrasias_and_Myeloproliferative_Disease::Multiple_Myeloma
#AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::03_Oncology::05_Plasma_Cell_Dyscrasias_SOAP #AK_Step1_v12::#OME::PreClinical::13_Hematology_Oncology::04_Proliferation::05_Plasma_Cell_Dyscrasis #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::26_Plasma_cell_dyscrasias::01_Multiple_myeloma #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step2_v12::#Resources_by_rotation::IM::ome::heme/onc::plasma_cell !AK_UpdateTags::AnKing_Image::Mujeeb::Plasma_Cell_Dyscrasias #AK_Step1_v12::#SketchyPath::10_Myeloid_&_Lymphoid::02_Lymphoid_&_Plasma_Cell_Disorders::04_Plasma_Cell_Neoplasms #AK_Step2_v12::Original_decks::Dorian::im::ome::heme/onc::plasma_cell #AK_Step1_v12::^Systems::HemeOnc::WBC !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Hematology-&-Oncology::Pathoma-WBC #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_WBC #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::26_Plasma_cell_dyscrasias #AK_Step2_v12::#AMBOSS::gF0Fh3 #AK_Step1_v12::#AMBOSS::x4aElk #AK_Step1_v12::#OME::13_Hematology_Oncology::04_Proliferation::05_Plasma_Cell_Dyscrasis #AK_Step2_v12::#OME::05_Heme_Onc::07_Plasma_Cell #AK_Step1_v12::#Pixorize::01_Biochemistry::19_Plasma_Cell_Dyscrasias::02_Multiple_Myeloma #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::03_White_Cells::01_Plasma_Cell_Disorders #AK_Step1_v12::#UWorld::Step::15466 #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::10_Plasma_Cell_Dyscrasias_&_Myeloproliferative_Disease::01_Multiple_Myeloma #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::18_Plasma_Cell_Dyscrasias #AK_Step2_v12::#AMBOSS::XF09g3 #AK_Step2_v12::#UWorld::COMLEX::101252 #AK_Step2_v12::#UWorld::Step::4466 #AK_Step1_v12::#UWorld::COMLEX::26337 #AK_Step1_v12::#Pathoma::06_WBC::08_Plasma_Cell_(Dyscrasias) #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step1_v12::#B&B::11_Hematology::03_White_Blood_Cells::05_Plasma_Cell_Disorders